Cytochrome p450 oxidase sto1, encoding gene and application thereof

By identifying and cloning the cytochrome P450 oxidase STO1 from potato, and constructing an engineered strain of Saccharomyces cerevisiae, the problem of the lack of identification of the key enzyme in the synthesis of spirotropin was solved, and the efficient synthesis of spirotropin was achieved, laying the foundation for industrial production.

CN121022946BActive Publication Date: 2026-06-19YUNNAN NORMAL UNIV
2 Cites 0 Cited by

Patent Information

Application Number
CN202511575782.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-10-31
Publication Date
2026-06-19
Estimated Expiration
2045-10-31

AI Technical Summary

Technical Problem

The cytochrome P450 oxidase responsible for catalyzing the synthesis of spirotropin has not yet been cloned and identified from potatoes, limiting in-depth research on the biosynthetic mechanism of spirotropin and its industrial production.

Method used

Cytochrome P450 oxidase STO1 was identified and cloned from potatoes. By constructing an engineered strain of Saccharomyces cerevisiae, genetic modification and heterologous expression technologies were used to catalyze the conversion of tofu zearalenone into spirophyllotoxin and/or spirophyllotoxin ketone. This included replacing the ERG9 genome with the weak promoter HXT1, expressing cytochrome P450 oxidase STO1, cytochrome P450 reductase AtCPR, and terpene synthase STS.

Benefits of technology

The efficient heterologous synthesis of spirochetone was achieved, with a laboratory shake flask yield of 291 mg/L, providing a theoretical basis for industrial production and enriching the diversity of cytochrome P450 oxidases.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

This invention relates to a cytochrome P450 oxidase STO1, its encoding gene, and its applications. This invention is the first to clone and identify a cytochrome P450 oxidase gene, STO1, from potato responsible for catalyzing the synthesis of spirogelothoraxone, and to determine the nucleotide sequence and translated amino acid sequence of this gene. This invention provides expression vectors, recombinant microorganisms, or transgenic cell lines containing this gene. This invention constructs an engineered Saccharomyces cerevisiae strain for producing spirogelothoraxone, in which the strong promoter ERG9 is replaced by the weak promoter HXT1 in the strain's genome, and the STO1, AtCPR, tHMG1, and STS genes are integrated. This invention also provides a method for constructing this engineered strain and a method for producing spirogelothoraxone using this engineered strain, which can be used for the preparation of spirogelothoraxone.
Need to check novelty before this filing date? Find Prior Art